Literature DB >> 15654227

Outcomes from intensive training in genetic cancer risk counseling for clinicians.

Kathleen R Blazer1, Deborah J MacDonald, Charite Ricker, Sharon Sand, Gwen C Uman, Jeffrey N Weitzel.   

Abstract

PURPOSE: Genetic cancer risk assessment is an emerging interdisciplinary practice that requires knowledge of genetics and oncology and specialized patient and family counseling skills. There is a growing need for cancer risk assessment practitioners, but most clinicians have inadequate cross-disciplinary training. An interdisciplinary course was developed to promote practitioner-level competency in cancer risk assessment to community-based clinicians. METHODS Participants were competitively selected from a pool of board-certified/eligible genetic counseling, masters-trained advanced practice nursing and physician applicants. Preference was given to clinicians with strong institutional backing practicing in underserved regions. The Continuing Medical Education/Continuing Education Unit-accredited course included didactic lectures, workshops, counseling practicum, and case conferences. Pre- and postcourse knowledge tests measured cancer genetics knowledge. Six month and one-year postcourse practice outcome surveys measured the impact of the program on professional self-efficacy and continued professional development. RESULTS/
CONCLUSIONS: Forty clinicians completed the course (23 genetic counselors, 14 nurses, and three physicians). There was a significant overall increase of 22.6% in postcourse knowledge scores (P < 0.001). Thirty-five (88%) completed prescribed practice development activities. Of 29 respondents to 1-year postcourse survey, 76% reported increased professional self-efficacy; 66% reported increase in number of patients seen, and virtually all indicated interest in additional training. Outcomes demonstrate the value and efficacy of interdisciplinary training in genetic cancer risk assessment targeted to motivated community-based clinicians. Courses such as this can help address the need for competent cancer risk assessment services in communities outside the academic health center.

Entities:  

Mesh:

Year:  2005        PMID: 15654227     DOI: 10.1097/01.gim.0000151154.27612.49

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  13 in total

Review 1.  Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Authors:  Jeffrey N Weitzel; Kathleen R Blazer; Deborah J MacDonald; Julie O Culver; Kenneth Offit
Journal:  CA Cancer J Clin       Date:  2011-08-19       Impact factor: 508.702

2.  Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.

Authors:  Allison H West; Kathleen R Blazer; Jessica Stoll; Matthew Jones; Caroline M Weipert; Sarah M Nielsen; Sonia S Kupfer; Jeffrey N Weitzel; Olufunmilayo I Olopade
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

3.  If we build it ... will they come?--establishing a cancer genetics services clinic for an underserved predominantly Latina cohort.

Authors:  Charité Ricker; Veronica Lagos; Nancy Feldman; Susan Hiyama; Sue Fuentes; Visanth Kumar; Kelly Gonzalez; Melanie Palomares; Kathleen Blazer; Katrina Lowstuter; Deborah MacDonald; Jeffrey Weitzel
Journal:  J Genet Couns       Date:  2006-12       Impact factor: 2.537

Review 4.  Genetic Cancer Risk Assessment for Breast Cancer in Latin America.

Authors:  Yanin Chavarri-Guerra; Kathleen Reilly Blazer; Jeffrey Nelson Weitzel
Journal:  Rev Invest Clin       Date:  2017 Mar-Apr       Impact factor: 1.451

5.  Impact of web-based case conferencing on cancer genetics training outcomes for community-based clinicians.

Authors:  Kathleen R Blazer; Christina Christie; Gwen Uman; Jeffrey N Weitzel
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

6.  Genetic education for primary care providers: improving attitudes, knowledge, and confidence.

Authors:  June C Carroll; Andrea L Rideout; Brenda J Wilson; Judith Md Allanson; Sean M Blaine; Mary Jane Esplen; Sandra A Farrell; Gail E Graham; Jennifer MacKenzie; Wendy Meschino; Fiona Miller; Preeti Prakash; Cheryl Shuman; Anne Summers; Sherry Taylor
Journal:  Can Fam Physician       Date:  2009-12       Impact factor: 3.275

7.  Mentoring nurses in familial cancer risk assessment and counseling: lessons learned from a formative evaluation.

Authors:  Agnes Masny; Mary E Ropka; Candace Peterson; Dominique Fetzer; Mary B Daly
Journal:  J Genet Couns       Date:  2008-01-26       Impact factor: 2.537

8.  Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of Florida.

Authors:  S T Vadaparampil; C L Scherr; D Cragun; T L Malo; T Pal
Journal:  Clin Genet       Date:  2014-05-09       Impact factor: 4.438

9.  Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings.

Authors:  Kathleen R Blazer; Bita Nehoray; Ilana Solomon; Mariana Niell-Swiller; Julie O Culver; Gwen C Uman; Jeffrey N Weitzel
Journal:  Genet Test Mol Biomarkers       Date:  2015-11-05

10.  Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce.

Authors:  Kathleen R Blazer; Deborah J Macdonald; Julie O Culver; Carin R Huizenga; Robert J Morgan; Gwen C Uman; Jeffrey N Weitzel
Journal:  Genet Med       Date:  2011-09       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.